Literature DB >> 15071739

Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Yesim Gürbüz1, Günter Klöppel.   

Abstract

Duodenal carcinomas, such as ampullary tumors, may be a heterogeneous group of neoplasms that share differentiation features with gastric or colorectal carcinomas. Because of the cell- and tissue-specific expression patterns of mucins and trefoil peptides, these markers were used to investigate the differentiation status of duodenal and ampullary carcinomas in comparison with gastric and colorectal carcinomas. Adenocarcinomas (14 duodenal, 10 gastric, 11 ampullary and 10 colorectal) were examined immunohistochemically for the mucin gene products MUC1, MUC2, MUC5AC, MUC6 and the trefoil peptides TFF1 and TFF2. The tumors' expression profile for MUC5AC, MUC6 and TFF1 was used to distinguish between gastric- and intestinal-directed differentiation. The mucins that were most often expressed in the individual tumor types were MUC1 (duodenal and ampullary carcinomas), MUC2 (colorectal carcinomas) and MUC5AC (gastric carcinomas). Further classification focusing on the expression profile for MUC5AC, MUC6 and TFF1 revealed that 21% of the duodenal and 45% of the ampullary carcinomas demonstrated mainly gastric differentiation (positivity for all three markers or only two of them). The remaining duodenal and ampullary carcinomas showed nongastric, i.e., intestinal differentiation (all three markers negative or only one marker positive). The gastric differentiation pattern characterized 60% of gastric carcinomas. Colorectal carcinomas showed intestinal differentiation in 100% of cases. Duodenal carcinomas have a heterogeneous mucin expression pattern that is mainly related to either gastric differentiation or intestinal differentiation. This also holds for ampullary carcinomas. Among the markers used, MUC5AC, MUC6 and TFF1 are most useful for revealing differentiation pathways in duodenal and ampullary carcinoma. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071739     DOI: 10.1007/s00428-004-1008-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

Review 1.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

2.  Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts.

Authors:  J Albores-Saavedra; L Murakata; J E Krueger; D E Henson
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

3.  Immunohistochemical detection of gastric mucin in normal and disease states.

Authors:  K L Taylor; A S Mall; R A Barnard; S B Ho; J P Cruse
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

4.  Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines.

Authors:  F Carvalho; L David; J P Aubert; A López-Ferrer; C De Bolós; C A Reis; F Gärtner; A Peixoto; P Alves; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  1999-11       Impact factor: 4.064

5.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

Authors:  N A Wright; R Poulsom; G Stamp; S Van Noorden; C Sarraf; G Elia; D Ahnen; R Jeffery; J Longcroft; C Pike
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

6.  Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: expression in normal GI tract and colon tumors.

Authors:  Séverine Nollet; Marie-Elisabeth Forgue-Lafitte; Paul Kirkham; Jacques Bara
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

7.  Differential expression of the chromosome 11 mucin genes in colorectal cancer.

Authors:  P A Sylvester; N Myerscough; B F Warren; I Carlstedt; A P Corfield; P Durdey; M G Thomas
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

8.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

Review 9.  Small bowel tumors: an overview.

Authors:  B G O'Riordan; M Vilor; L Herrera
Journal:  Dig Dis       Date:  1996 Jul-Aug       Impact factor: 2.404

10.  Expression of mucins and cytokeratins in primary carcinomas of the digestive system.

Authors:  Min Jong Lee; Hye Seung Lee; Woo Ho Kim; Yunhee Choi; Mihi Yang
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

View more
  9 in total

1.  KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.

Authors:  Wei Tang; Yoshinori Inagaki; Norihiko Kokudo; Qian Guo; Yasuji Seyama; Munehiro Nakata; Hiroshi Imamura; Keiji Sano; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

2.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

3.  Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.

Authors:  Sebastian Dwertmann Rico; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Thies Daniels; Christoph Isbert; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Eike Burandt; Andreas Marx; Till Krech
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

4.  Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

Authors:  Shinichi Yachida; Laura D Wood; Masami Suzuki; Erina Takai; Yasushi Totoki; Mamoru Kato; Claudio Luchini; Yasuhito Arai; Hiromi Nakamura; Natsuko Hama; Asmaa Elzawahry; Fumie Hosoda; Tomoki Shirota; Nobuhiko Morimoto; Kunio Hori; Jun Funazaki; Hikaru Tanaka; Chigusa Morizane; Takuji Okusaka; Satoshi Nara; Kazuaki Shimada; Nobuyoshi Hiraoka; Hirokazu Taniguchi; Ryota Higuchi; Minoru Oshima; Keiichi Okano; Seiko Hirono; Masamichi Mizuma; Koji Arihiro; Masakazu Yamamoto; Michiaki Unno; Hiroki Yamaue; Matthew J Weiss; Christopher L Wolfgang; Toru Furukawa; Hitoshi Nakagama; Bert Vogelstein; Tohru Kiyono; Ralph H Hruban; Tatsuhiro Shibata
Journal:  Cancer Cell       Date:  2016-01-21       Impact factor: 31.743

5.  Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.

Authors:  Yasunari Kawabata; Tsuneo Tanaka; Takashi Nishisaka; Touko Inao; Takeshi Nishi; Seiji Yano
Journal:  Diagn Pathol       Date:  2010-11-25       Impact factor: 2.644

6.  Mucins differently expressed in various ampullary adenocarcinomas.

Authors:  Tao Wang; Ye M Liang; Peng Hu; Yu F Cheng
Journal:  Diagn Pathol       Date:  2011-10-25       Impact factor: 2.644

7.  Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps.

Authors:  Angela N Bartley; Patricia A Thompson; Julie A Buckmeier; Carole Y Kepler; Chiu-Hsieh Hsu; Manuel S Snyder; Peter Lance; Achyut Bhattacharyya; Stanley R Hamilton
Journal:  Mod Pathol       Date:  2009-10-23       Impact factor: 7.842

8.  The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance.

Authors:  Qian Xu; Li-Ping Sun; Ben-Gang Wang; Jing-Wei Liu; Ping Li; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-08-09

9.  Signet ring cell carcinoma of the ampulla of Vater: Immunophenotype and differentiation.

Authors:  Xue Wen; Weiqiang Wu; Bo Wang; Hongtian Yao; Xiaodong Teng
Journal:  Oncol Lett       Date:  2014-07-11       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.